Antibodies to GABAA receptor α1 and γ2 subunits: Clinical and serologic characterization

Neurology

Volumn 84, Issue 12, 2015, Pages 1233-1241

  Pettingill, Philippa ^a   Kramer, Holger B ^b   Coebergh, Jan Adriaan ^c   Pettingill, Rosie ^a   Maxwell, Susan ^a   Nibber, Anjan ^a   Malaspina, Andrea ^d   Jacob, Anu ^e   Irani, Sarosh R ^a   Buckley, Camilla ^a   Beeson, David ^a   Lang, Bethan ^a   Waters, Patrick ^a   Vincent, Angela ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1; 4 AMINOBUTYRIC ACID A RECEPTOR ALPHA1 ANTIBODY; 4 AMINOBUTYRIC ACID A RECEPTOR GAMMA2; 4 AMINOBUTYRIC ACID A RECEPTOR GAMMA2 ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID A RECEPTOR; GABRA1 PROTEIN, HUMAN; GABRG1 PROTEIN, HUMAN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; AGED; ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; BRAIN CELL CULTURE; BRAIN NERVE CELL; CATATONIA; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONFUSION; DISORIENTATION; FEMALE; GENETIC TRANSFECTION; HALLUCINATION; HEK293 CELL LINE; HIPPOCAMPUS; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; IMMUNOPRECIPITATION; IMMUNOTHERAPY; IN VITRO STUDY; MALE; MEMORY DISORDER; NEUROLOGIC DISEASE; NONHUMAN; ONSET AGE; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEIZURE; TREATMENT RESPONSE; ANIMAL; BLOOD; CASE REPORT; IMMUNOLOGY; NERVE CELL; PATHOPHYSIOLOGY;

ADOLESCENT; ANIMALS; ANTIBODY SPECIFICITY; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; FEMALE; HEK293 CELLS; HIPPOCAMPUS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; NEURONS; RATS; RECEPTORS, GABA-A;

EID: 84925431020     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001326     Document Type: Article

References (23)

1. Dalmau J, Tüzün E, Wu H, Masjuan J. Paraneoplastic anti-N methyl Daspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007;61:25-36.
2. Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009;65:424-434.
3. Lancaster E, Lai M, Peng X, et al. Antibodies to the GABAB receptor in limbic encephalitis with seizures. Case series and characterisation of the antigen. Lancet Neurol 2010;9:67-76.
4. Irani S, Michell A, Lang B, Pettingill P. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 2011;69:1-9.
5. Brenner T, Sills GJ, Hart Y, et al. Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy. Epilepsia 2013;54:1028-1035.
6. Steiner J, Walter M, Glanz W, et al. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. JAMA Psychiatry 2013;70:271-278.
7. Tsutsui K, Kanbayashi T, Tanaka K, et al. Anti-NMDAreceptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features. BMC Psychiatry 2012;12:37.
8. Vincent A, Bien CG, Irani SR, Waters P. Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol 2011;10:759-772.
9. Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody-associated encephalopathy. A potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004;127:701-712.
10. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDAreceptor encephalitis. Case series and analysis of the effects of antibodies. Lancet Neurol 2008;7:1091-1098.
11. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis. An observational cohort study. Lancet Neurol 2013;12:157-165.
12. Petit-Pedrol M, Armangue T, Peng X, et al. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor. A case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol 2014;13:276-286.
13. Leite MI, Jacob S, Viegas S, et al. IgG1 antibodies to acetylcholine receptors in "seronegative" myasthenia gravis. Brain 2008;131:1940-1952.
14. Waters P, Jarius S, Littleton E, et al. Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. Arch Neurol 2008;65:913-919.
15. Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 2010;133:2734-2748.
16. Pirker S, Schwarzer C, Wieselthaler A, Sieghart W, Sperk G. GABAA receptors: Immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 2000;101:815-850.
17. Hughes EG, Peng X, Gleichman AJ, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 2010;30:5866-5875.
18. Northoff G, Steinke R, Czcervenka C, et al. Decreased density of GABA-A receptors in the left sensorimotor cortex in akinetic catatonia: Investigation of in vivo benzodiazepine receptor binding. J Neurol Neurosurg Psychiatry 1999;67:445-450.
19. Wiebking C, Duncan NW, Qin P, et al. External awareness and GABA. A multimodal imaging study combining fMRI and [18F]flumazenil-PET. Hum Brain Mapp 2014; 35:173-184.
20. Rogawski MA, Löscher W. The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nat Med 2004;10:685-692. Review.
21. Ohkawa T, Satake S, Yokoi N, et al. Identification and characterization of GABA(A) receptor autoantibodies in autoimmune encephalitis. J Neurosci 2014;34:8151-8163.
22. Prüss H, Finke C, Höltje M, et al. N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis. Ann Neurol 2012;72:902-911.
23. Prüss H, Höltje M, Maier N, Gomez A, Buchert R. IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment. Neurology 2012;78: 1743-1753.